Jan O. Korbel

European Molecular Biology Laboratory (EMBL), Heidelberg, Baden-Württemberg, Germany 
"Jan Korbel"
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Roidos P, Sungalee S, Benfatto S, et al. (2020) A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice. Nature Communications. 11: 4077
Drainas AP, Lambuta RA, Ivanova I, et al. (2020) Genome-wide Screens Implicate Loss of Cullin Ring Ligase 3 in Persistent Proliferation and Genome Instability in TP53-Deficient Cells. Cell Reports. 31: 107465
Calabrese C, Davidson NR, et al. (2020) Genomic basis for RNA alterations in cancer. Nature. 578: 129-136
Chaisson MJP, Sanders AD, Zhao X, et al. (2019) Multi-platform discovery of haplotype-resolved structural variation in human genomes. Nature Communications. 10: 1784
Gerhauser C, Favero F, Risch T, et al. (2018) Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell. 34: 996-1011.e8
Segura-Wang M, Onishi-Seebacher M, Stütz AM, et al. (2017) Systematic Identification of Determinants for Single Strand Annealing Mediated Deletion Formation in Saccharomyces cerevisiae. G3 (Bethesda, Md.)
Weischenfeldt J, Dubash T, Drainas AP, et al. (2016) Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nature Genetics
Tica J, Lee E, Untergasser A, et al. (2016) Next-generation sequencing-based detection of germline L1-mediated transductions. Bmc Genomics. 17: 342
Coccé MC, Mardin BR, Bens S, et al. (2016) Identification of ZCCHC8 as Fusion Partner of ROS1 in a case of Congenital Glioblastoma Multiforme with a t(6;12)(q21;q24.3). Genes, Chromosomes & Cancer
Schütze DM, Krijgsman O, Snijders PJ, et al. (2016) Immortalization capacity of HPV types is inversely related to chromosomal instability. Oncotarget
See more...